Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Dermatofibrosarcoma Protuberans: What Is This?
Gerardo A Vitiello1, Ann Y Lee2, Russell S Berman3
1Department of Surgery, Division of Surgical Oncology, New York University Langone Health, 550 First Avenue, NBV 15 North-1, New York, NY 10016, USA. Electronic address: https://twitter.com/GerardoVitiello.
Abstract:
Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive dermal-based sarcoma. Metastatic potential is extremely low, primarily in the setting of fibrosarcomatous transformation. DFSP is characterized by a t(17;22) (q22;q13) translocation that results in active PDGFB signaling. Surgical resection with negative margins (typically including the underlying fascia) is the potentially curative treatment. Delayed wound closure should be considered for cases requiring extensive resection or tissue rearrangement. Tyrosine kinase inhibitors, such as imatinib, have shown response rates of 50% to 60% in patients with locally advanced or metastatic disease. Radiation can be useful for residual or recurrent diseases.

